Skip to content

A study to see how a single increasing dose of the oral drug AD-700 affects the ability of a CT scan to detect activated brown fat in healthy people

Status
Suspended
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-520584-41-00
Acronym
IBT-002
Enrollment
18
Registered
2025-05-05
Start date
2025-06-05
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolism dysfunction

Interventions

None listed

Sponsors

Adiposs S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026